iRhythm Holdings, Inc. Stock-Based Compensation
iRhythm Holdings, Inc. (IRTC) reported Stock-Based Compensation of $41.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $20.04M, a 12.21% decline year-over-year.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $21.49M, a 7.94% decline year-over-year.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $21.11M, a 31.85% increase year-over-year.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $21.01M, a 22.43% increase year-over-year.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $88.28M, a 16.20% increase from fiscal 2024.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $75.98M, a 1.59% decline from fiscal 2023.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $77.20M, a 33.71% increase from fiscal 2022.
- iRhythm Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $57.74M, a 5.89% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $41.53M 10-Q · filed 2026-08-06 | $62.64M derived: sum of 3 quarters · filed 2026-08-06 | $83.64M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $21.49M 10-Q · filed 2026-04-30 | $42.60M derived: sum of 2 quarters · filed 2026-04-30 | $63.60M derived: sum of 3 quarters · filed 2026-04-30 | $86.43M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $21.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $42.11M derived: sum of 2 quarters · filed 2026-02-19 | $64.94M derived: sum of 3 quarters · filed 2026-08-06 | $88.28M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $21.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $43.83M derived: sum of 2 quarters · filed 2026-08-06 | $67.18M 10-Q · filed 2025-10-30 | $83.19M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $22.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $46.17M 10-Q · filed 2026-08-06 | $62.18M derived: sum of 3 quarters · filed 2026-08-06 | $79.34M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $23.34M 10-Q · filed 2026-04-30 | $39.35M derived: sum of 2 quarters · filed 2026-04-30 | $56.51M derived: sum of 3 quarters · filed 2026-04-30 | $78.33M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $16.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $33.17M derived: sum of 2 quarters · filed 2026-02-19 | $54.99M derived: sum of 3 quarters · filed 2026-02-19 | $75.98M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $17.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $38.98M derived: sum of 2 quarters · filed 2025-10-30 | $59.97M 10-Q · filed 2025-10-30 | $83.82M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $21.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $42.81M 10-Q · filed 2025-07-31 | $66.66M derived: sum of 3 quarters · filed 2026-02-19 | $87.67M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $20.99M 10-Q · filed 2025-05-01 | $44.84M derived: sum of 2 quarters · filed 2026-02-19 | $65.84M derived: sum of 3 quarters · filed 2026-02-19 | $79.94M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $23.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $44.85M derived: sum of 2 quarters · filed 2026-02-19 | $58.95M derived: sum of 3 quarters · filed 2026-02-19 | $77.20M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $21.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $35.11M derived: sum of 2 quarters · filed 2024-10-30 | $53.36M 10-Q · filed 2024-10-30 | $69.15M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $32.35M 10-Q · filed 2024-08-01 | $48.14M derived: sum of 3 quarters · filed 2025-02-20 | $61.09M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | $18.25M 10-Q · filed 2024-05-02 | $34.05M derived: sum of 2 quarters · filed 2025-02-20 | $46.99M derived: sum of 3 quarters · filed 2025-02-20 | $62.09M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $28.74M derived: sum of 2 quarters · filed 2025-02-20 | $43.84M derived: sum of 3 quarters · filed 2025-02-20 | $57.74M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $12.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $28.04M derived: sum of 2 quarters · filed 2023-11-02 | $41.95M 10-Q · filed 2023-11-02 | $53.82M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $29.00M 10-Q · filed 2023-08-04 | $40.88M derived: sum of 3 quarters · filed 2024-02-22 | $53.04M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | $13.90M 10-Q · filed 2023-05-04 | $25.78M derived: sum of 2 quarters · filed 2024-02-22 | $37.94M derived: sum of 3 quarters · filed 2024-02-22 | $48.20M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | $11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $24.04M derived: sum of 2 quarters · filed 2024-02-22 | $34.30M derived: sum of 3 quarters · filed 2024-02-22 | $54.53M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $12.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $22.42M derived: sum of 2 quarters · filed 2022-11-04 | $42.65M 10-Q · filed 2022-11-04 | $56.65M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | $10.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $30.49M 10-Q · filed 2022-08-05 | $44.49M derived: sum of 3 quarters · filed 2023-02-23 | $61.93M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | $20.23M 10-Q · filed 2022-05-06 | $34.23M derived: sum of 2 quarters · filed 2023-02-23 | $51.67M derived: sum of 3 quarters · filed 2023-02-23 | $61.44M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $31.44M derived: sum of 2 quarters · filed 2023-02-23 | $41.21M derived: sum of 3 quarters · filed 2023-02-23 | $41.52M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $17.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $27.21M derived: sum of 2 quarters · filed 2021-11-05 | $27.52M 10-Q · filed 2021-11-05 | $34.69M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $9.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $10.07M 10-Q · filed 2021-08-09 | $17.25M derived: sum of 3 quarters · filed 2022-02-28 | $24.65M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $305.00K 10-Q · filed 2021-05-10 | $7.48M derived: sum of 2 quarters · filed 2022-02-28 | $14.88M derived: sum of 3 quarters · filed 2022-02-28 | $21.69M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $14.58M derived: sum of 2 quarters · filed 2022-02-28 | $21.39M derived: sum of 3 quarters · filed 2022-02-28 | $26.24M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $14.21M derived: sum of 2 quarters · filed 2020-11-06 | $19.06M 10-Q · filed 2020-11-06 | $23.86M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | $6.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $11.66M 10-Q · filed 2020-08-07 | $11.74M 10-Q · filed 2019-08-06 | $16.46M derived: sum of 3 quarters · filed 2021-02-26 | $20.67M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $4.86M 10-Q · filed 2020-05-08 | $4.42M 10-Q · filed 2019-05-10 | $9.65M derived: sum of 2 quarters · filed 2021-02-26 | $13.86M derived: sum of 3 quarters · filed 2021-02-26 | $17.94M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $9.01M derived: sum of 2 quarters · filed 2021-02-26 | $13.08M derived: sum of 3 quarters · filed 2021-02-26 | $16.33M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | $8.29M derived: sum of 2 quarters · filed 2019-12-23 | $11.53M 10-Q · filed 2019-12-23 | $14.26M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.32M 10-Q · filed 2019-08-06 | $10.05M derived: sum of 3 quarters · filed 2020-03-02 | $12.78M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $3.25M 10-Q · filed 2019-05-10 | $5.97M derived: sum of 2 quarters · filed 2020-03-02 | $8.71M derived: sum of 3 quarters · filed 2020-03-02 | $10.97M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.46M derived: sum of 2 quarters · filed 2020-03-02 | $7.72M derived: sum of 3 quarters · filed 2020-03-02 | $9.75M 10-K · filed 2020-03-02 | $10.12M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $5.00M derived: sum of 2 quarters · filed 2018-10-30 | $7.02M 10-Q · filed 2018-10-30 | $7.64M derived: sum of 4 quarters · filed 2019-03-04 | |||
| 2017-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.29M 10-Q · filed 2018-08-03 | $4.91M derived: sum of 3 quarters · filed 2019-03-04 | $5.31M derived: sum of 4 quarters · filed 2019-03-04 | |||
| 2017-03-31 | $2.03M 10-Q · filed 2018-05-10 | $2.65M derived: sum of 2 quarters · filed 2019-03-04 | $3.05M derived: sum of 3 quarters · filed 2019-03-04 | $3.49M derived: sum of 4 quarters · filed 2019-03-04 | |||
| 2016-12-31 | $620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $1.02M derived: sum of 2 quarters · filed 2019-03-04 | $1.46M derived: sum of 3 quarters · filed 2019-03-04 | $1.87M 10-K · filed 2019-03-04 | |||
| 2016-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $843.00K derived: sum of 2 quarters · filed 2017-11-14 | $1.25M 10-Q · filed 2017-11-14 | $1.63M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $850.00K 10-Q · filed 2017-08-07 | $1.23M derived: sum of 3 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $408.00K 10-Q · filed 2017-05-12 | $783.00K derived: sum of 2 quarters · filed 2018-03-01 | |||||
| 2015-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.41M 10-K · filed 2018-03-01 | |||||
| 2015-09-30 | $1.03M 10-Q · filed 2016-12-05 | ||||||
| 2014-12-31 | $828.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |